L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents
ATC class of level 3 – pharmacological subgroup
This page lists the patient medication information or the product monograph for 118 drugs in this drug class and its subclasses.
- 118 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
-
L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 16 drugs
- L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 3 drugs
- L01ED Anaplastic lymphoma kinase (ALK) inhibitors 4 drugs
- L01EE Mitogen-activated protein kinase (MEK) inhibitors 5 drugs
- L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
- L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 1 drug
- L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 5 drugs
- L01EJ Janus-associated kinase (JAK) inhibitors 3 drugs
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 4 drugs
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 3 drugs
- L01EX Other protein kinase inhibitors 30 drugs
-
L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
- Abemaciclib 1 drug
- Acalabrutinib 1 drug
- Acalabrutinib (acalabrutinib maleate) 1 drug
- Afatinib (afatinib dimaleate) 4 drugs
- Alectinib (alectinib hydrochloride) 1 drug
- Alpelisib 1 drug
- Asciminib (asciminib hydrochloride) 1 drug
- Avapritinib 1 drug
- Axitinib 2 drugs
- Binimetinib 1 drug
- Bosutinib (bosutinib dihydrate) 1 drug
- Bosutinib (bosutinib monohydrate) 2 drugs
- Cabozantinib (cabozantinib malate) 1 drug
- Capivasertib 1 drug
- Capmatinib (capmatinib hydrochloride) 1 drug
- Ceritinib 1 drug
- Cobimetinib (cobimetinib fumarate) 1 drug
- Crizotinib 1 drug
- Dabrafenib (dabrafenib mesylate) 1 drug
- Dacomitinib (dacomitinib monohydrate) 1 drug
- Dasatinib 2 drugs
- Dasatinib (dasatinib (s)-propylene glycol) 1 drug
- Dasatinib (dasatinib monohydrate) 3 drugs
- Encorafenib 1 drug
- Entrectinib 1 drug
- Erdafitinib 1 drug
- Erlotinib (erlotinib hydrochloride) 5 drugs
- Fedratinib (fedratinib hydrochloride) 1 drug
- Fruquintinib 1 drug
- Gefitinib 4 drugs
- Idelalisib 1 drug
- Imatinib (imatinib mesylate) 15 drugs
- Inavolisib 1 drug
- Infigratinib (infigratinib phosphate) 1 drug
- Lapatinib (lapatinib ditosylate) 1 drug
- Larotrectinib (larotrectinib sulfate) 1 drug
- Lazertinib (lazertinib mesylate) 1 drug
- Lenvatinib (lenvatinib mesylate) 1 drug
- Lorlatinib 1 drug
- Midostaurin 1 drug
- Momelotinib (momelotinib dihydrochloride) 1 drug
- Neratinib (neratinib maleate) 1 drug
- Nilotinib (nilotinib hydrochloride dihydrate) 1 drug
- Nilotinib (nilotinib hydrochloride monohydrate) 3 drugs
- Nintedanib (nintedanib esilate) 5 drugs
- Osimertinib (osimertinib mesylate) 1 drug
- Palbociclib 5 drugs
- Pazopanib (pazopanib hydrochloride) 5 drugs
- Pirtobrutinib 1 drug
- Ponatinib (ponatinib hydrochloride) 1 drug
- Pralsetinib 1 drug
- Quizartinib (quizartinib hydrochloride) 1 drug
- Regorafenib 1 drug
- Repotrectinib 1 drug
- Ribociclib (ribociclib succinate) 1 drug
- Ripretinib 1 drug
- Ruxolitinib (ruxolitinib phosphate) 1 drug
- Selpercatinib 1 drug
- Selumetinib (selumetinib sulfate) 1 drug
- Sevabertinib 1 drug
- Sorafenib (sorafenib tosylate) 2 drugs
- Sunitinib (sunitinib malate) 5 drugs
- Temsirolimus 1 drug
- Tepotinib (tepotinib hydrochloride) 1 drug
- Tovorafenib 1 drug
- Trametinib 2 drugs
- Tucatinib 1 drug
- Zanubrutinib 1 drug
- Zongertinib 1 drug
Drugs in the class and its subclasses
Other classes of the same level
- L01A Alkylating agents 61 drugs
- L01B Antimetabolites 118 drugs
- L01C Plant alkaloids and other natural products, antineoplastic drugs 75 drugs
- L01D Cytotoxic antibiotics and related substances 49 drugs
- L01X Other antineoplastic agents 120 drugs
Other names of the drug class
- English (United Kingdom): L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents
- German: L01E Proteinkinase-Inhibitoren
- German (Austria): L01E PROTEINKINASE-INHIBITOREN
- Italian: L01E Inibitori della protein chinasi
- Turkish: L01E PROTEİN KİNAZ İNHİBİTÖRLERİ, ANTİNEOPLASTİK VE İMMUNOMODÜLATÖR AJANLAR
- Czech: L01E Inhibitory proteinkináz
- Slovak: L01E Inhibítory proteínkinázy
- German (Switzerland): L01E Proteinkinase-Inhibitoren
- Italian (Switzerland): L01E Inibitori della protein chinasi
- Dutch: L01E Proteïnekinaseremmers, oncolytica en immunomodulerende middelen
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01E
Ask your doctor or pharmacist for advice.